Through this partnership, HempStreet aims to build solutions to help them in their fight against mass ailments.
HempStreet, India's first research to retail venture in the ayurvedic cannabis sector, has partnered with Amrita School of Ayurveda. Amrita School of Ayurveda, based in Kerala, was founded in 2004 and is a well-known Ayurvedic education facility both nationally and internationally. Through this collaboration, HempStreet aims to receive clinically supported solutions to aid in their fight against mass ailments.
.jpg) |
HempStreet started with the vision to harness the power of ayurveda and utilize responsibly dispensed cannabis based medication to tackle chronic ailments. HempStreet’s partnership with Amrita School of Ayurveda is one step further to meet the nation's needs of managing ailments through modern Ayurveda. Amrita School of Ayurveda, part of Amrita University, is ranked fifth in the National Institutional Ranking Framework (NIRF) Rankings 2021. Amrita School takes a unique approach to blending ancient philosophies and health science by cultivating a new breed of Ayurvedic physicians to fulfill the mission of creating a patient-centered and integrated health care delivery system.
Commenting on the partnership, Abhishek Mohan, Founder & CEO, HempStreet, said, “We are very excited to announce this partnership with Amrita School of Ayurveda and its affiliate R&D organizations to work towards clinical validation of formulations to address several mass ailments. This aligns with our policy of partnering with the best in class. With this partnership, we strive to further our mission to harness the power of Ayurveda via cannabis-based medication with a layer of clinical validation. This fits our global strategy of best-in-class partnerships across Europe, the US and Israel.”
Adding to this, Dr P. Ram Manohar, Head, Centre for Advanced Research In Ayurveda (ACARA), said, "We are thrilled to be collaborating with HempStreet. Our goal is to promote the expansion and advancement of Ayurvedic education, and working with HempStreet will help us close the knowledge gap between cutting-edge technological advancements and traditional medicine based on ancient wisdom. By bringing tradition and scientific research together, we can pave the way for contemporizing Ayurveda to meet global health care needs.”
HempStreet is poised to reshape the way mass ailments are addressed by raising awareness about the use of cannabis for pain management to address one of the health sector's most pressing issues. The company recently collaborated with over 400 Ayurvedic doctors in Mumbai to bolster this. Furthermore, to strengthen the R&D and distribution segment, HempStreet also partnered with MGC Pharma and Gynica earlier this year.
Commenting on the partnership, Abhishek Mohan, Founder & CEO, HempStreet, said, “We are very excited to announce this partnership with Amrita School of Ayurveda and its affiliate R&D organizations to work towards clinical validation of formulations to address several mass ailments. This aligns with our policy of partnering with the best in class. With this partnership, we strive to further our mission to harness the power of Ayurveda via cannabis-based medication with a layer of clinical validation. This fits our global strategy of best-in-class partnerships across Europe, the US and Israel.”
Adding to this, Dr P. Ram Manohar, Head, Centre for Advanced Research In Ayurveda (ACARA), said, "We are thrilled to be collaborating with HempStreet. Our goal is to promote the expansion and advancement of Ayurvedic education, and working with HempStreet will help us close the knowledge gap between cutting-edge technological advancements and traditional medicine based on ancient wisdom. By bringing tradition and scientific research together, we can pave the way for contemporizing Ayurveda to meet global health care needs.”
HempStreet is poised to reshape the way mass ailments are addressed by raising awareness about the use of cannabis for pain management to address one of the health sector's most pressing issues. The company recently collaborated with over 400 Ayurvedic doctors in Mumbai to bolster this. Furthermore, to strengthen the R&D and distribution segment, HempStreet also partnered with MGC Pharma and Gynica earlier this year.
About HempStreet
HempStreet is India's first research to retail medicinal cannabis venture, working towards amalgamating the age-old science of Ayurveda with modern cannabis research to develop sustainable and economical solutions for mass ailments. All of this while ensuring end-to-end blockchain technology-based supply chain tracking to minimize any chance of abuse. HempStreet's dispensation network of more than 11000 partner clinics across 26 states of India is a testament to the efficacy of the formulations and the trust of medical practitioners in the brand. The company is also India's first medicinal cannabis venture to have been awarded the prestigious Biotechnology Ignition Grant (BIG) of BIRAC. Recently HempStreet partnered with Gynica, an R&D company based out of Israel focused on changing the culture of gynecological treatment through clinically proven, cannabinoid-based solutions.About Amrita School of Ayurveda:
Amrita School of Ayurveda, Amritapuri was established in 2004 and managed by Mata Amritanandamayi Math Trust. The college has developed into a prestigious centre for education in Ayurveda, nationally as well as internationally, under the gracious guidance of its founder and spiritual guru, Mata Amritanandamayi Devi. The mission of the school is to provide a value-based education and mold the character of our younger generation through synergy of science and spirituality so that their earnest endeavor to achieve progress and prosperity in life is matched by an ardent desire to extend selfless service to the society, one complementing the other.
Advertisements